Literature DB >> 8652601

Influence of dose on liposome clearance: critical role of blood proteins.

C D Oja1, S C Semple, A Chonn, P R Cullis.   

Abstract

It is well established that the circulation half-life of liposomes increases with increasing dose. This effect is commonly attributed to "saturation' of the fixed and free macrophages of the reticuloendothelial system resulting in reduced clearance rates. However, it is also known that the clearance rate of liposomes is dependent on the amount of associated blood protein, leading to the possibility that dose-dependent increases in circulation lifetimes could be due to decreases in the amount of blood protein associated per liposome. In order to test this hypothesis, the protein binding and clearance properties of large unilamellar liposomes composed of distearoylphosphatidylcholine/cholesterol and egg phosphatidylcholine/dioleoylphosphatidic acid/cholesterol were examined in mice. Liposomes were injected over a dose range of 10 to 1000 mg lipid/kg body weight, and the circulation lifetime and liver and spleen accumulation monitored. As expected, longer circulation half-lives were observed at higher doses for both liposome compositions. However, it was also found that at higher liposome doses, significantly less protein was bound per liposome. The results indicate that there is a limited pool of blood proteins that is able to interact with liposomes of a given composition. At higher lipid doses these blood proteins are distributed over more liposomes resulting in lower protein binding values and longer circulation lifetimes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652601     DOI: 10.1016/0005-2736(96)00003-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.

Authors:  Robert D Arnold; Donald E Mager; Jeanine E Slack; Robert M Straubinger
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

2.  Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

Authors:  E W van Etten; M T ten Kate; S V Snijders; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 3.  Functional lipids and lipoplexes for improved gene delivery.

Authors:  Xiao-Xiang Zhang; Thomas J McIntosh; Mark W Grinstaff
Journal:  Biochimie       Date:  2011-05-20       Impact factor: 4.079

4.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

5.  Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery.

Authors:  Nicholas J Baumhover; Jason T Duskey; Sanjib Khargharia; Christopher W White; Samuel T Crowley; Rondine J Allen; Kevin G Rice
Journal:  Mol Pharm       Date:  2015-11-05       Impact factor: 4.939

6.  Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density.

Authors:  V C Mosqueira; P Legrand; J L Morgat; M Vert; E Mysiakine; R Gref; J P Devissaguet; G Barratt
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

7.  Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent.

Authors:  Zhijin Chen; Dexin Yu; Shaojie Wang; Na Zhang; Chunhong Ma; Zaijun Lu
Journal:  Nanoscale Res Lett       Date:  2009-03-18       Impact factor: 4.703

8.  Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.

Authors:  Federico Pea; Domenico Russo; Mariagrazia Michieli; Daniela Damiani; Renato Fanin; Angela Michelutti; Teresa Michelutti; Stefano Piccolrovazzi; Michele Baccarani; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation.

Authors:  Randall Toy; Elliott Hayden; Andrew Camann; Zachary Berman; Peter Vicente; Emily Tran; Joseph Meyers; Jenna Pansky; Pubudu M Peiris; Hanping Wu; Agata Exner; David Wilson; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  ACS Nano       Date:  2013-03-14       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.